Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.
Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.
复制标题
DOI:
10.1038/s41598-022-14935-y
复制
发表时间:
2022-07-20
影响因子:
4.6
通讯作者:
Robinson, Richard T.
中科院分区:
文献类型:
--
作者:
Gunasena, Manuja;Shukla, Rajni Kant;Yao, Naiquan;Mejia, Oscar Rosas;Powell, Michael D.;Oestreich, Kenneth J.;de Jesus Aceves-Sanchez, Michel;Alberto Flores-Valdez, Mario;Liyanage, Namal P. M.;Robinson, Richard T.
The vaccine Mycobacterium bovis Bacillus Calmette-Guérin (BCG) elicits an immune response that is protective against certain forms of tuberculosis (TB); however, because BCG efficacy is limited it is important to identify alternative TB vaccine candidates. Recently, the BCG deletion mutant and vaccine candidate BCGΔBCG1419c was demonstrated to survive longer in intravenously infected BALB/c mice due to enhanced biofilm formation, and better protected both BALB/c and C57BL/6 mice against TB-induced lung pathology during chronic stages of infection, relative to BCG controls. BCGΔBCG1419c-elicited protection also associated with lower levels of proinflammatory cytokines (i.e. IL6, TNFα) at the site of infection in C57BL/6 mice. Given the distinct immune profiles of BCG- and BCGΔBCG1419c-immunized mice during chronic TB, we set out to determine if there are early immunological events which distinguish these two groups, using multi-dimensional flow cytometric analysis of the lungs and other tissues soon after immunization. Our results demonstrate a number of innate and adaptive response differences between BCG- and BCGΔBCG1419c-immunized mice which are consistent with the latter being longer lasting and potentially less inflammatory, including lower frequencies of exhausted CD4+ T helper (TH) cells and higher frequencies of IL10-producing T cells, respectively. These studies suggest the use of BCGΔBCG1419c may be advantageous as an alternative TB vaccine candidate.
登录
查看更多内容
DOI:
10.4049/jimmunol.1601231
发表时间:
2017-10-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Cheekatla SS;Tripathi D;Venkatasubramanian S;Paidipally P;Welch E;Tvinnereim AR;Nurieva R;Vankayalapati R
通讯作者:
Vankayalapati R
影响因子:
3.3
作者:
Ackart DF;Hascall-Dove L;Caceres SM;Kirk NM;Podell BK;Melander C;Orme IM;Leid JG;Nick JA;Basaraba RJ
通讯作者:
Basaraba RJ
影响因子:
6.4
作者:
Faulkner, L;Buchan, G;Baird, M
通讯作者:
Baird, M
影响因子:
6.4
作者:
Guinn KM;Rubin EJ
通讯作者:
Rubin EJ
影响因子:
4.6
作者:
Alberto Flores-Valdez, Mario;de Jesus Aceves-Sanchez, Michel;Waters, Christopher M.
通讯作者:
Waters, Christopher M.